These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 26192403)

  • 1. Different Procoagulant Activity of Therapeutic Mesenchymal Stromal Cells Derived from Bone Marrow and Placental Decidua.
    Moll G; Ignatowicz L; Catar R; Luecht C; Sadeghi B; Hamad O; Jungebluth P; Dragun D; Schmidtchen A; Ringdén O
    Stem Cells Dev; 2015 Oct; 24(19):2269-79. PubMed ID: 26192403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placenta-Derived Decidua Stromal Cells for Treatment of Severe Acute Graft-Versus-Host Disease.
    Ringden O; Baygan A; Remberger M; Gustafsson B; Winiarski J; Khoein B; Moll G; Klingspor L; Westgren M; Sadeghi B
    Stem Cells Transl Med; 2018 Apr; 7(4):325-331. PubMed ID: 29533533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decidual stromal cells promote regulatory T cells and suppress alloreactivity in a cell contact-dependent manner.
    Erkers T; Nava S; Yosef J; Ringdén O; Kaipe H
    Stem Cells Dev; 2013 Oct; 22(19):2596-605. PubMed ID: 23701127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placenta-Derived Decidua Stromal Cells: A New Frontier in the Therapy of Acute Graft-Versus-Host Disease.
    Ringdén O; Sadeghi B
    Stem Cells; 2024 Apr; 42(4):291-300. PubMed ID: 38204331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of decidual stromal cells in an epidermolysis bullosa patient and in allogeneic hematopoietic stem cell transplantation patients.
    Kaipe H; Carlson LM; Erkers T; Nava S; Molldén P; Gustafsson B; Qian H; Li X; Hashimoto T; Sadeghi B; Alheim M; Ringdén O
    Stem Cells Dev; 2015 Jun; 24(12):1471-82. PubMed ID: 25658253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal Stromal Cells in Pediatric Hematopoietic Cell Transplantation a Review and a Pilot Study in Children Treated With Decidua Stromal Cells for Acute Graft-versus-Host Disease.
    Ringdén O; Gustafsson B; Sadeghi B
    Front Immunol; 2020; 11():567210. PubMed ID: 33193339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human decidual stromal cells secrete C-X-C motif chemokine 13, express B cell-activating factor and rescue B lymphocytes from apoptosis: distinctive characteristics of follicular dendritic cells.
    Muñoz-Fernández R; Prados A; Leno-Durán E; Blázquez A; García-Fernández JR; Ortiz-Ferrón G; Olivares EG
    Hum Reprod; 2012 Sep; 27(9):2775-84. PubMed ID: 22718279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placenta-Derived Decidua Stromal Cells for Hemorrhagic Cystitis after Stem Cell Transplantation.
    Aronsson-Kurttila W; Baygan A; Moretti G; Remberger M; Khoein B; Moll G; Sadeghi B; Ringdén O
    Acta Haematol; 2018; 139(2):106-114. PubMed ID: 29408819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical Toxicity Evaluation of Clinical Grade Placenta-Derived Decidua Stromal Cells.
    Sadeghi B; Moretti G; Arnberg F; Samén E; Kohein B; Catar R; Kamhieh-Milz J; Geissler S; Moll G; Holmin S; Ringdén O
    Front Immunol; 2019; 10():2685. PubMed ID: 31803191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone Marrow-Derived Mesenchymal Stem Cells Have Innate Procoagulant Activity and Cause Microvascular Obstruction Following Intracoronary Delivery: Amelioration by Antithrombin Therapy.
    Gleeson BM; Martin K; Ali MT; Kumar AH; Pillai MG; Kumar SP; O'Sullivan JF; Whelan D; Stocca A; Khider W; Barry FP; O'Brien T; Caplice NM
    Stem Cells; 2015 Sep; 33(9):2726-37. PubMed ID: 25969127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome.
    Ringdén O; Moll G; Gustafsson B; Sadeghi B
    Front Immunol; 2022; 13():839844. PubMed ID: 35371003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Follow-Up of a Pilot Study Using Placenta-Derived Decidua Stromal Cells for Severe Acute Graft-versus-Host Disease.
    Sadeghi B; Remberger M; Gustafsson B; Winiarski J; Moretti G; Khoein B; Klingspor L; Westgren M; Mattsson J; Ringdén O
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):1965-1969. PubMed ID: 31173898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin improves BMSC cell therapy: Anticoagulant treatment by heparin improves the safety and therapeutic effect of bone marrow-derived mesenchymal stem cell cytotherapy.
    Liao L; Shi B; Chang H; Su X; Zhang L; Bi C; Shuai Y; Du X; Deng Z; Jin Y
    Theranostics; 2017; 7(1):106-116. PubMed ID: 28042320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in mice.
    Jang MJ; Kim HS; Lee HG; Kim GJ; Jeon HG; Shin HS; Chang SK; Hur GH; Chong SY; Oh D; Chung HM
    Acta Haematol; 2013; 129(4):197-206. PubMed ID: 23257958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of radiculomyelopathy in two patients with placenta-derived decidua stromal cells.
    Sadeghi B; Ersmark B; Moretti G; Mattsson J; Ringdén O
    Int J Hematol; 2020 Apr; 111(4):591-594. PubMed ID: 31853810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human term placenta-derived mesenchymal stromal cells are less prone to osteogenic differentiation than bone marrow-derived mesenchymal stromal cells.
    Pilz GA; Ulrich C; Ruh M; Abele H; Schäfer R; Kluba T; Bühring HJ; Rolauffs B; Aicher WK
    Stem Cells Dev; 2011 Apr; 20(4):635-46. PubMed ID: 21047215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow-derived mesenchymal stem cell transplantation for chronic spinal cord injury in rats: comparative study between intralesional and intravenous transplantation.
    Kim JW; Ha KY; Molon JN; Kim YH
    Spine (Phila Pa 1976); 2013 Aug; 38(17):E1065-74. PubMed ID: 23629485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
    Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
    Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Zhao K; Lou R; Huang F; Peng Y; Jiang Z; Huang K; Wu X; Zhang Y; Fan Z; Zhou H; Liu C; Xiao Y; Sun J; Li Y; Xiang P; Liu Q
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):97-104. PubMed ID: 25300866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow-derived conventional, but not cloned, mesenchymal stem cells suppress lymphocyte proliferation and prevent graft-versus-host disease in rats.
    Kitazawa Y; Li XK; Xie L; Zhu P; Kimura H; Takahara S
    Cell Transplant; 2012; 21(2-3):581-90. PubMed ID: 22793067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.